Get the Stockscreener App
12.46
1.35%
0.20
Optimizerx Corp stock is traded at $12.46, with a volume of 136.70K.
It is up +1.35% in the last 24 hours and down -11.94% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$12.26
Open:
$12.38
24h Volume:
136.70K
Relative Volume:
0.49
Market Cap:
$233.75M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-15.58
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-0.44%
1M Performance:
-11.94%
6M Performance:
-5.30%
1Y Performance:
+138.48%
1-Day Range:
$11.75
$12.54
1-Week Range:
$11.75
$12.58
52-Week Range:
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
12.54 | 228.53M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
220.28 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
61.68 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.87 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.91 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.91 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Head to Head Comparison: Manhattan Associates (NASDAQ:MANH) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) Insider Sells $18,751.88 in Stock - MarketBeat
OptimizeRx CFO sells $18,751 in shares By Investing.com - Investing.com Nigeria
OptimizeRx CFO sells $18,751 in shares - Investing.com
OptimizeRx Corp Executive Sells Shares - TradingView — Track All Markets
How OptimizeRx Corporation stock responds to policy changesMarket Rally & Stepwise Trade Signal Implementation - Улправда
Is OptimizeRx Corporation stock oversold or undervaluedRecession Risk & AI Forecast for Swing Trade Picks - Улправда
Is OptimizeRx Corporation stock a good choice for value investors2025 EndofYear Setup & High Accuracy Investment Signals - DonanımHaber
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Hold” at Zacks Research - Defense World
OptimizeRx (NASDAQ:OPRX) Cut to "Hold" at Zacks Research - MarketBeat
OPRX FinancialsIncome Statement - Quiver Quantitative
OptimizeRx Corp. Expands Point-of-Care Network with Four New Partner Agreements - Quiver Quantitative
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network - The Manila Times
New partnerships plug drug makers into more doctors’ EHR workflows - Stock Titan
Officer D'Silva Surrenders 868 Of OptimizeRx Corp [OPRX] - TradingView — Track All Markets
OptimizeRx Corp (OPRX) insider has 868 shares withheld for taxes - Stock Titan
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to “Strong-Buy” - Defense World
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to "Strong-Buy" - MarketBeat
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Cut to "Buy" at Wall Street Zen - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Buy” at Wall Street Zen - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
Financial Comparison: OptimizeRx (NASDAQ:OPRX) and SS&C Technologies (NASDAQ:SSNC) - Defense World
OptimizeRx Corporation (OPRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How Recent Developments Are Shaping the OptimizeRx Investment Story - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
OptimizeRx Corporation's (NASDAQ:OPRX) 33% Share Price Plunge Could Signal Some Risk - simplywall.st
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - MarketBeat
Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat
Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com
Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
OptimizeRx CorporationCommon Stock (NQ: OPRX - Markets Financial Content
Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat
OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener
How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
OptimizeRx (OPRX) Analyst Rating Update: Stephens & Co. Lowers P - GuruFocus
Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX - MarketBeat
When is the best time to exit OptimizeRx Corporation2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Published on: 2025-11-16 12:30:34 - newser.com
Will OptimizeRx Corporation stock maintain momentum in 20252025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Brendan W. Merrell Net Worth (2025) - GuruFocus
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward | Chief Finance & Strat Officer |
Dec 19 '25 |
Sale |
13.51 |
1,388 |
18,752 |
126,830 |
| Silvestro Stephen L | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
195,462 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
3,928 |
0 |
94,526 |
| Besch Doug | Chief Product & Tech Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
1,964 |
0 |
71,536 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
92,550 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
3.25%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):